Back to search
FDAFDA · Food and drugs·Recall number D-0867-2026

Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.

Published September 30, 2026 · Recall initiated: August 27, 2026

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Recall details

Brand
OLANZAPINE
Manufacturer
Macleods Pharmaceuticals Limited
Distributor
Nationwide in the USA
UPC
0333342067074
Lot
Lot: BOB22321A, Exp 07-31-2027.
Risk classification
Class III
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07. recalled?

Yes. FDA published recall D-0867-2026 on September 30, 2026. Reported hazard: Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: OLANZAPINE. UPC: 0333342067074.

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Recalert also tracks expiration dates so you can sell stock before it becomes a loss.

Check your inventory (free)